Triflupromazine versus pentylenetetrazol-nicotinic acid for treatment of chronic brain disease on a general-hospital psychiatric service.
D000368:Aged; D003704:Dementia / Q000188:drug therapy*; D005260:Female; D006801:Humans; D002537:Intracranial Arteriosclerosis / Q000188:drug therapy*; D008297:Male; D009539:Nicotinic Acids / Q000009:adverse effects / Q000627:therapeutic use*; D010433:Pentylenetetrazole / Q000009:adverse effects / Q000627:therapeutic use*; D011569:Psychiatric Status Rating Scales; D011581:Psychological Tests; D013997:Time Factors; D014273:Triflupromazine / Q000009:adverse effects / Q000627:therapeutic use*
D009539:Nicotinic Acids; D014273:Triflupromazine; D010433:Pentylenetetrazole